U.S. Water Utilities Stock News

Q4 earnings beat and AI focus put Progress Software (PRGS) in the spotlight Progress Software (PRGS) has moved back into focus after a strong Q4 earnings beat, with management highlighting AI driven growth plans, tighter cost controls, and revenue opportunities across its AI powered software platforms. See our latest analysis for Progress Software. At a share price of US$40.84, Progress Software has seen strong short term momentum, with a 7 day share price return of 11.8%, even though its 1...

Rollins, Inc. recently reported higher fourth-quarter and full-year 2025 earnings, continued to signal a healthy M&A pipeline, and earlier this month presented its outlook at Barclays’ 43rd Annual Industrial Select Conference in Miami. Management’s emphasis on recurring revenue, disciplined acquisitions, and confidence in funding further deals after investing almost US$900 million over three years highlights how central M&A has become to Rollins’ growth ambitions. We’ll now examine how...

Neurocrine Biosciences (NBIX) is back in focus after reporting fourth quarter and full year 2025 earnings, alongside fresh 2026 sales guidance for INGREZZA and optimistic commentary around its late stage pipeline. See our latest analysis for Neurocrine Biosciences. At a latest share price of US$128.38, Neurocrine Biosciences has seen short term share price pressure, with a 30 day share price return of a 5.73% decline and a 90 day share price return of a 10.56% decline. However, a 1 year total...

Why ICU Medical is back on investors’ radar ICU Medical (ICUI) has moved back into focus after resolving a longstanding FDA warning letter tied to its Smiths Medical business and posting fourth quarter results with adjusted earnings above analyst expectations, along with 2026 guidance that came in ahead of consensus. The company paired these updates with detailed 2026 earnings guidance, giving investors clearer visibility into expected GAAP net income of US$26 million to US$44 million and...

Trinity Industries (TRN) is back in focus after its latest quarterly results and 2026 earnings outlook, which highlighted higher net income and earnings per share along with lower sales compared with the prior year. See our latest analysis for Trinity Industries. At a share price of $34.60, Trinity Industries has given investors a 28.0% 1 month share price return and 31.2% 3 month share price return. Its 1 year total shareholder return of 19.4% points to momentum that has been building rather...

Americold Realty Trust, Inc. reported fourth-quarter 2025 results showing sales of US$600.68 million and revenue of US$658.45 million, with net loss widening to US$88.34 million and loss per share from continuing operations at US$0.31. Alongside these weaker results, the company introduced a new Chief Financial Officer, Chris Papa, and set out a detailed 2026 plan focused on balance sheet repair, cost reductions, and targeted growth in higher-value cold storage segments. Next, we’ll examine...

Gentherm (THRM) is back in focus after reporting fourth quarter and full year 2025 results that showed much lower net income alongside record revenue, along with new revenue guidance for 2026 and 2027. See our latest analysis for Gentherm. The latest results and 2026 to 2027 revenue guidance came as the share price closed at $32.51, with a 1 day share price return of 4.69% decline and a 1 year total shareholder return of 4.35% decline. This points to pressure on the Gentherm story after...

UGI stock reacts to Q1 earnings and business reshaping UGI (UGI) is in focus after Q1 FY 2026 earnings, a major business reshaping in Europe, senior leadership changes, and expansion into new U.S. states drew fresh attention to the stock. See our latest analysis for UGI. At a share price of US$37.45, UGI has seen a 1 day share price return of 2.19% decline and a softer 7 day and 30 day share price return. However, its 1 year total shareholder return of 17.38% and 5 year total shareholder...

If you are wondering whether SBA Communications is attractively priced or still looks expensive at around US$199.64, starting with a clear view of its valuation can help you frame the opportunity and the risks. The stock has been relatively flat over the last week with a 0.6% decline, while the 30 day return sits at 6.7% and the 1 year return at a 4.3% decline. Some investors may see this as a reset after a 19.0% decline over 3 years and a 13.6% decline over 5 years. Recent coverage has...

If you are wondering whether Euronet Worldwide's current share price still reflects its true worth, you are not alone. This article is built to help you assess that question clearly. The stock last closed at US$70.53, with a 3.8% return over the past 7 days, but longer term returns sit at a 4.8% decline year to date and a 30.7% decline over the past year. This may have changed how some investors view its risk and potential. Recent coverage of Euronet Worldwide has focused on its position...

PPL Corporation (NYSE:PPL) announced a public offering of 20 million equity units. Each equity unit combines a stock purchase contract with an interest in remarketable senior notes. The transaction is structured as a capital markets offering to raise funding for the company. PPL is a regulated utility holding company focused on electricity, an area that continues to attract investor attention because of its link to essential services and long term infrastructure investment. For shareholders...

If you are wondering whether Chord Energy's share price still reflects good value or if the opportunity has passed, looking closely at how the market is pricing the business can give you useful clues. The stock recently closed at US$105.25, with returns of 3.2% over the past 7 days, 10.2% over the last 30 days, 11.2% year to date and a 0.3% decline over the last year, which may leave investors debating whether this is renewed enthusiasm or a reassessment of risk. Recent news flow around...

Comstock Resources (CRK) is back in focus after a sharp 8.86% share price drop over the past week, driven mainly by weaker natural gas prices despite recently reported 2025 earnings and new growth plans. See our latest analysis for Comstock Resources. Beyond the recent week, Comstock Resources has seen its share price weaken more broadly, with a 30 day share price return of 23.04% and a 90 day share price return of 25.86%. Even though the 5 year total shareholder return of 229.92% still...

Sana Biotechnology (SANA) has been drawing attention after a mixed stretch in its share performance, with a small gain over the past week contrasting with a decline over the past month. See our latest analysis for Sana Biotechnology. At the current share price of $4.07, Sana Biotechnology has seen a 5.71% 7 day share price return and a 15.95% 90 day share price return. Its 1 year total shareholder return of 41.32% contrasts with a 5 year total shareholder return loss of 87.76%, suggesting...

In February 2026, Cal-Maine Foods reported the passing of long-serving director Jim Poole, whose audit, financial and governance expertise had shaped key board committees for over two decades. At the same time, new institutional interest and a US$36.00 million investment to expand prepared foods capacity highlighted Cal-Maine’s focus on higher-value egg products and product mix evolution. Next, we’ll examine how Cal-Maine’s planned 30%+ prepared foods capacity expansion could influence its...

Amicus Therapeutics (FOLD) has drawn investor attention after a strong past 3 months, with a total return of about 45% and a 1-year total return above 50%, prompting closer scrutiny of its fundamentals. See our latest analysis for Amicus Therapeutics. The recent move in Amicus Therapeutics' share price to $14.36 sits on top of a strong 90 day share price return of about 45%, while the 1 year total shareholder return of roughly 54% points to momentum that has been building rather than...

Stepan (SCL) has wrapped up FY 2025 with fourth quarter revenue of US$553.9 million and basic EPS of US$0.22, while trailing twelve month figures show revenue of about US$2.3 billion and EPS of US$2.05. Over recent periods, revenue has moved from US$546.8 million in Q3 2024 to the US$590.3 million to US$594.7 million range across the first three quarters of 2025, with quarterly EPS ranging from US$0.47 to US$0.86, and trailing EPS shifting between US$2.01 and US$2.54. With a trailing net...

In February 2026, Forum Energy Technologies reported that Q4 2025 sales were US$202.2 million with net income of US$2.07 million, while completing a US$35.00 million buyback of 1.40 million shares, or 11.68% of its stock, under the repurchase plan announced in December 2024. The company exited 2025 with a US$312.0 million order backlog, the largest in 11 years, and issued 2026 guidance calling for US$800.0–US$880.0 million in revenue, highlighting how improved earnings, a stronger order...

CubeSmart (NYSE:CUBE) has entered a $250 million joint venture with CBRE Investment Management. The partnership is focused on expanding CubeSmart's presence in high growth self storage markets. The new venture comes as the self storage market shows signs of recovery and renewed investor interest. For investors watching NYSE:CUBE at a share price of $39.66, this move adds a fresh layer to the story. The stock is up 12.0% year to date and has returned 34.6% over 5 years, while 1 year and 3...

If you are wondering whether Sempra is fairly priced or if there could be value left on the table, starting with the recent share performance and valuation checks can help frame that question. Sempra shares last closed at US$93.60, with returns of 8.9% over 30 days, 4.3% year to date, 10.9% over 1 year, 33.1% over 3 years, and 86.2% over 5 years. Recent coverage of Sempra has focused on its role as a US utilities player, investor interest in income and infrastructure names, and how these...

If you are wondering whether Harmony Biosciences Holdings is attractively priced or misunderstood by the market, you are not alone. This article will walk through what the current share price really implies. The stock last closed at US$26.87, after declines of 25.4% over the past week, 27.0% over the past month, and 21.4% over the past year. These moves may have changed how investors view both its potential and its risks. Recent news coverage around Harmony Biosciences has focused on the...

Dollar Tree recently raised its full-year EPS guidance after reporting a strong quarter, including 4.2% comparable sales growth and 12% adjusted EPS growth to US$1.21, while analysts highlighted both benefits from a Supreme Court tariff ruling and concerns about valuation and limited e-commerce presence. An interesting angle is how the company’s multi-price strategy and potential tariff relief may support margin recovery even as some analysts turn cautious. Next, we’ll examine how Dollar...

Community Financial System (NYSE:CBU) has appointed Brenda M. Hall as a new independent director to its Board. Hall previously served as chief operating officer in the insurance industry, with experience in enterprise strategy, risk management, and regulatory oversight. The appointment is intended to deepen the Board’s expertise in governance and oversight for shareholders and other stakeholders. Community Financial System, the parent of Community Bank, operates as a regional financial...

What the new P-8A contracts tell you about OSS’s business mix One Stop Systems (OSS) has secured US$10.5 million in new awards tied to the P-8A Poseidon aircraft, the largest aggregate orders it has reported for this platform so far. For you as a shareholder or prospective investor, this indicates two things at once: confirmed demand from U.S. defense customers and clearer forward visibility, since OSS expects these awards to contribute to revenue in 2026 and continue into 2027. The contracts...